adamantane has been researched along with lactic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bucolo, C; Caputi, A; Cuzzocrea, S; Drago, F; Marrazzo, A; Mazzon, E; Ronsisvalle, G; Ronsisvalle, S | 1 |
| Ban, HS; Harmalkar, D; Hwang, GS; Kim, BK; Kim, HM; Kim, I; Lee, H; Lee, K; Nam, M; Park, JT; Park, SK; Won, M | 1 |
2 other study(ies) available for adamantane and lactic acid
| Article | Year |
|---|---|
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors.
Topics: Adamantane; Adenosine Triphosphate; Animals; Anisoles; Glucose; Lactic Acid; Male; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Reperfusion Injury; Retina; Retinal Diseases | 2006 |
The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.
Topics: Adamantane; Animals; Antineoplastic Agents; Cell Proliferation; Colorectal Neoplasms; Cyclic AMP; Female; Gene Expression Regulation, Neoplastic; Glucose; Glycolysis; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic Acid; Mice; Mice, Nude; NAD; Neovascularization, Pathologic; Piperazines; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase; Signal Transduction; TOR Serine-Threonine Kinases; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays | 2017 |